Holen Sie sich die Stockscreener-App
80.16
0.51%
0.41
Handel nachbörslich:
80.16
Schlusskurs vom Vortag:
$79.75
Offen:
$79.76
24-Stunden-Volumen:
1.06M
Relative Volume:
1.19
Marktkapitalisierung:
$13.85B
Einnahmen:
$8.26B
Nettoeinkommen (Verlust:
$66.00M
KGV:
217.71
EPS:
0.3682
Netto-Cashflow:
$1.17B
1W Leistung:
+5.09%
1M Leistung:
+8.94%
6M Leistung:
+25.58%
1J Leistung:
+0.00%
1-Tages-Spanne:
$78.41
$81.93
1-Wochen-Bereich:
$77.91
$85.92
52-Wochen-Spanne:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Branche
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
80.16 | 13.85B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
VEEV
Veeva Systems Inc
|
218.95 | 35.55B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
68.45 | 12.84B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
104.82 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
50.93 | 8.77B | 640.44M | -743.28M | -206.93M | -11.29 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Don't Give up on the Turnaround Titan - MD+DI
Solventum Corporation (NYSE:SOLV) Q4 2024 Earnings Call Transcript - MSN
Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports - MSN
Positive week for Solventum Corporation (NYSE:SOLV) institutional investors who control 64% of the company - Simply Wall St
Solventum (NYSE:SOLV) Price Target Raised to $84.00 at Piper Sandler - MarketBeat
Is 3M Stock a Buy Now? - The Motley Fool
Anchor Capital Advisors LLC Sells 24,448 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum Co. (NYSE:SOLV) Holdings Cut by Pine Valley Investments Ltd Liability Co - MarketBeat
Ieq Capital LLC Acquires 14,780 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum (NYSE:SOLV) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Allspring Global Investments Holdings LLC Trims Stock Position in Solventum Co. (NYSE:SOLV) - MarketBeat
Handelsbanken Fonder AB Takes Position in Solventum Co. (NYSE:SOLV) - MarketBeat
Private Advisor Group LLC Boosts Stock Holdings in Solventum Co. (NYSE:SOLV) - MarketBeat
Facing tariffs and a big sale, Solventum sees profits slide - MSN
Why Solventum (SOLV) Stock Is Down Today - The Globe and Mail
Solventum (NYSE:SOLV) Price Target Raised to $85.00 at Bank of America - MarketBeat
Solventum (NYSE:SOLV) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
What Analysts Are Saying About Solventum Stock - Benzinga
Solventum (NYSE:SOLV) Releases FY 2025 Earnings Guidance - MarketBeat
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Why Solventum (SOLV) Stock Is Down Today By Stock Story - Investing.com Canada
Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit - MSN
Thermo Fisher Scientific Agreed to Acquire Solventum’s Purification and Filtration Business - Genetic Engineering & Biotechnology News
SOLV Stock Down Despite Q4 Earnings & Revenues Beat Estimates - Yahoo Finance
Solventum: Q4 EPS Beats, Cash Flow Dips - sharewise
Solventum beats The Street in Q4 — but stock is down - Mass Device
Biotechnology company Thermo Fisher Scientific buys Solventum’s filtration and purification business for $4.1 billion - BioProcess Insider
Piper Sandler raises Solventum price target to $84, keeps neutral rating - Investing.com
Solventum, facing sagging profit, sells purification business to Thermo Fisher for $4.1 billion - MSN
New York State Common Retirement Fund Sells 5,201 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum: Q4 Earnings Snapshot - Thehour.com
Solventum Reports Strong Revenue but EPS Declines in Q4 2024News and Statistics - IndexBox, Inc.
Solventum Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Solventum forecasts annual profit above estimates on strong surgical product sales - MSN
Truist Financial Corp Sells 3,921 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Earnings call transcript: Solventum’s Q4 2024 earnings miss expectations, stock drops By Investing.com - Investing.com South Africa
ING Groep NV Buys New Stake in Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates By Stock Story - Investing.com Canada
Earnings call transcript: Solventum’s Q4 2024 earnings miss expectations, stock drops - Investing.com
SOLVENTUM Earnings Results: $SOLV Reports Quarterly Earnings - Nasdaq
Solventum's Stellar Performance Puts Profit Above Forecasts - Finimize
Solventum shares fall as Q4 earnings miss estimates By Investing.com - Investing.com South Africa
Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates - Yahoo Finance UK
Solventum shares fall as Q4 earnings miss estimates - Investing.com
Solventum Provides FY25 Guidance - Nasdaq
Solventum Corporation Q4 Income Drops - Nasdaq
Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance - Nasdaq
Solventum Q4 24 Earnings Conference Call At 4:30 PM ET - Nasdaq
Thermo Fisher Scientific: $4.1 Billion Deal For Solventum’s Purification And Filtration Business - Pulse 2.0
Solventum Corp. credit rating on positive watch after P&F business sale agreementS&P Global By Investing.com - Investing.com South Africa
Apriem Advisors Makes New $333,000 Investment in Solventum Co. (NYSE:SOLV) - MarketBeat
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):